A new synthetic protein nanoparticle capable of
slipping past the nearly impermeable blood-brain barrier could
deliver cancer-killing drugs directly to malignant brain tumors,
new research from the University of Michigan shows.
A new synthetic protein nanoparticle capable of
slipping past the nearly impermeable blood-brain barrier could
deliver cancer-killing drugs directly to malignant brain tumors,
new research from the University of Michigan shows.